Favipiravir (FAV) has become a promising antiviral agent for the treatment of COVID-19. Herein, a green, fast, high-sample-throughput, non-instrumental, and affordable analytical method is proposed based on surfactant-assisted dispersive liquid–liquid microextraction (SA-DLLME) combined with thin-layer chromatography–digital image colourimetry (TLC-DIC) for determining favipiravir in biological and pharmaceutical samples. Triton X-100 and dichloromethane (DCM) were used as the disperser and extraction solvents, respectively. The extract obtained after DLLME procedure was spotted on a TLC plate and allowed to develop with a mobile phase of chloroform:methanol (8:2, v/v). The developed plate was photographed using a smartphone under UV irradiation at 254 nm. The quantification of FAV was performed by analysing the digital images’ spots with open-source ImageJ software. Multivariate optimisation using Plackett–Burman design (PBD) and central composite design (CCD) was performed for the screening and optimisation of significant factors. Under the optimised conditions, the method was found to be linear, ranging from 5 to 100 µg/spot, with a correlation coefficient (R2) ranging from 0.991 to 0.994. The limit of detection (LOD) and limit of quantification (LOQ) were in the ranges of 1.2–1.5 µg/spot and 3.96–4.29 µg/spot, respectively. The developed approach was successfully applied for the determination of FAV in biological (i.e., human urine and plasma) and pharmaceutical samples. The results obtained using the proposed methodology were compared to those obtained using HPLC-UV analysis and found to be in close agreement with one another. Additionally, the green character of the developed method with previously reported protocols was evaluated using the ComplexGAPI, AGREE, and Eco-Scale greenness assessment tools. The proposed method is green in nature and does not require any sophisticated high-end analytical instruments, and it can therefore be routinely applied for the analysis of FAV in various resource-limited laboratories during the COVID-19 pandemic.
Wetland degradation, driven by pollution and encroachment, presents a significant global challenge. This study explores the multi-country efficacy of Floating Treatment Wetland Systems (FTWS) as a Nature-based Solution (NbS) for remediating urban water bodies across Bangladesh, India and Nepal, using a common experimental framework that integrates an initially controlled microcosm study, followed by field trials engaging the community members and researchers for their capacity building. Since FTWS uses low-cost raft construction, and locally available and recycled materials, this enables direct cross-country comparison and scalability of the FTWS. Experiments show reductions of up to 99% in nitrate (highest in Nepal), up to 91% in orthophosphate (highest in Nepal), and up to 96% in biochemical oxygen demand (BOD) (highest in India). Across all sites, Canna indica emerged as a highly effective species for FTWS due to its robust nutrient uptake and its ability to survive in diverse environments and conditions. Field trials conducted at Dhanmondi Lake (Bangladesh), Nayagaon Talai (India) and Nagdaha (Nepal) demonstrated significant improvements in water quality, with increases in dissolved oxygen of up to 50% and reductions in nitrate and phosphate concentrations. The study also emphasised capacity building efforts, engaging communities through workshops and training sessions, thereby enhancing awareness and support for FTWS technology. This multi-country initiative underscores the potential of FTWS as a cost-effective NbS for improving urban water quality while fostering community engagement and wetland conservation.